IRadimed Corp (IRMD) stock

IRMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3060% above fair value

$85.35+0.12 (+0.14%)

Close on Nov 13, 2026Market cap $1.09BP/E 45.6Yield –

IRadimed total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

IRadimed has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is IRMD.

Revenue growth11.0% · median -0.8%

Gross margin75.5% · median 63.6%

Operating margin32.3% · median -9.6%

Net margin26.8% · median -29.1%

Advertisement
300 × 250

See a number that looks wrong?